![Petter Veiby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Petter Veiby
Founder at
ATTOVIA THERAPEUTICS, INC.
Net worth: 2 M $ as of 31/08/2026
Profile
Petter Veiby is the founder of Attovia Therapeutics, Inc., founded in 2022, serving as Chief Scientific Officer.
Mr. Veiby is currently Director at BiVictriX Therapeutics Plc since 2025.
Former jobs include Senior Director at Millennium Pharmaceuticals, Inc. from 2022 to 2023, Global Head-Biotherapeutics at Millennium Pharmaceuticals, Inc. from 1999 to 2020, and Senior Vice President-Business Development at Immunitas Therapeutics, Inc. in 2022.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 05/08/2026 | 1,04,952 ( 0.23% ) | 2 M $ | 31/08/2026 |
Petter Veiby active positions
| Companies | Position | Start |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Founder | 16/12/2022 |
| BIVICTRIX THERAPEUTICS PLC | Director/Board Member | 01/08/2025 |
Former positions of Petter Veiby
| Companies | Position | End |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/06/2023 |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Corporate Officer/Principal | 01/11/2022 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/03/2020 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
BiVictriX Therapeutics Plc
 BiVictriX Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and distributes cancer therapeutics | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
Attovia Therapeutics
 Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
- Stock Market
- Insiders
- Petter Veiby
